Filing Details

Accession Number:
0000885590-12-000076
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-14 21:40:57
Reporting Period:
2012-11-09
Filing Date:
2012-11-14
Accepted Time:
2012-11-14 21:40:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885590 Valeant Pharmaceuticals International Inc. VRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1477123 Mitchell Lloyd Segal 4787 Levy Street
Montreal A8 H4R 2P9
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2012-11-09 240 $54.28 17,849 No 4 P Indirect By Wife
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Wife
Footnotes
  1. This number represents the weighted average purchase price for all purchases of common stock purchased by the reporting officer. Actual purchases were in the range of $54.28 and $54.29. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each price.
  2. This number represents common shares purchased and other equity awards that were previously reported in Table 1.